Cystic fibrosis-related diabetes testing in Monte Argentario
Find health labs to test for Cystic fibrosis-related diabetes in Monte Argentario and compare all offers by prices and services.
test prediabete e diabete con autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€35.00
€33.25 with our promocode
See Details
Hemoglobin Test by Montalto Ckech-up s.r.l.
Strada Statale Castrense Campo Morto, 312, 01014 Montalto di Castro VT, Italia
25.6 km
Unverified
A Diabetes Test costs €50.00
See Details
Diabetes Test by Centro Polispecialistico Giovanni Paolo I Srl
Via Fernando Molini, 6, 01100 Viterbo VT, Italia
50.5 km
Diabetes Test by RDV - Rete Diagnostica Vesuviana
Via Giacomo Matteotti, 19, 01100 Viterbo VT, Italia
50.5 km
Hemoglobin Test by Centro Diagnostico Trasimeno Srl
Via Fratelli Rosselli, 8, 06061 Castiglione del Lago PG, Italia
67.2 km
Diabetes Test by Farmacia Genovesi
Via Roma, 1, 05030 Otricoli TR, Italia
69.5 km
Hemoglobin Test by Salvati Diagnostica - Poliambulatorio e Laboratorio Analisi
Via Tuderte, 426, 05035 Narni TR, Italia
71.5 km
Diabetes Test by Farmacia Conti Dott.Valentino
Via Gabelletta, 147B, 05100 Terni TR, Italia
78.4 km
Diabetes Test by Crabion S.R.L.
Via Amilcare Ponchielli, 8, 06073 Corciano PG, Italia
76.1 km
Unverified
A Diabetes Test costs €49.00
See Details
Hemoglobin Test by Filia Studio Patologia Clinica
Via Costantiniana, 28, 00188 Roma RM, Italia
79.6 km
Hemoglobin Test by Analisi Cliniche Prospero Colonna Srl
Corso Duca di Genova, 26, 00121 Roma RM, Italia
79.6 km
Unverified
A Diabetes Test costs €30.00
See Details
Cystic fibrosis-related diabetes - symptoms and how to test
Diabetes mellitus is a common disease; however, cystic fibrosis can cause a unique type of disease called cystic fibrosis-related diabetes (CFRD). This type of diabetes mellitus is different from both type 1, and type 2 diabetes yet has specific characteristics. The primary reason is insulin insufficiency due to islet cell death. Adults and adolescents with cystic fibrosis often develop diabetes because of their condition. Moreover, a third of CF patients aged 16 and up are receiving therapy for CFRD, according to 2018 data from the UK CF Registry. Among children aged 10 to 15, just 11% are receiving medication. There is evidence that early treatment of diabetes improves prognosis, and the fact that diabetes and poor glucose tolerance are both associated with worse health outcomes in people with CF emphasises the necessity of an early diagnosis.
